AzTrials
AzTrials

Carpal Tunnel SyndromeCTRMTANCT02766114

Carpal Tunnel Release Through Mini Transverse Approach

A study testing Carpal tunnel release through Mini Transverse Approach in people with Carpal Tunnel Syndrome and Carpal Tunnel Release, run by Issa, Abdulhamid Sayed, M.D. at 1 site in Syria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Carpal tunnel release through dorsal wrist crease Mini Transverse incision, about 1.5 cm length. Read more about this study

Who is it for?
Ages 16 to 70 years
What is being tested?
Carpal tunnel release through Mini Transverse Approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteSyria
Study dates
Feb 2013to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 70 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients presented with Carpal Tunnel Syndrome refractory to conservative treatment
  • Participant cooperation sufficient to operate under local anesthesia

Who cannot join

  • Un controlled diabetes mellitus type 1 and 2
  • Patients with non controlled Vascular hypertension
  • Significant renal disease, defined as a history of chronic renal failure requiring dialysis or kidney transplant.
  • Myocardial infarction, other acute cardiac event requiring hospitalization, stroke, transient ischemic attack, or treatment for acute congestive heart failure within 4 months prior to randomization
  • Patients with history of Carpal Tunnel release surgery failure

Trial locations and contacts

1 site in 1 country.

Syria1 site
  • Dr. Sayed Issa's Clinic

    Aleppo

Other trials in Syria

About this study

Carpal tunnel release through dorsal wrist crease Mini Transverse incision, about 1.5 cm length.

Read the detailed description

Carpal tunnel release through a small approach on the distal wrist crease, it is about 1.5 cm, the benefits of this technique is less surgical traumatic and more tender, it takes less time for rehabilitation, so the patient can work next day of operation, and it has very cosmetic and gentle scar in results and outcome.

Being tested
Carpal tunnel release through Mini Transverse Approach
Keywords
CTS, Carpal tunnel syndrome, Carpal tunnel release, Mini incision of carpal tunnel release, Cosmetic surgery of carpal tunnel syndrome, endoscopic carpal tunnel surgery, Carpal Tunnel Release Through Mini Transverse Approach, Dr. Sayed Issa's Approach, CTRMTA, OCTR, ECTR, Open Carpal Tunnel Release, Endoscopic Carpal Tunnel Release, Syria, Cosmetic, Safety, Rehabilitation,, Complications, Surgery, Satisfaction
Medical subject headings
Carpal Tunnel Syndrome, Personal Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Carpal tunnel release through Mini Transverse ApproachProcedure or surgery

    Carpal tunnel release through a transverse cosmetic small incision over the distal wrist crease.

Study groups in NCT02766114
Study groupRoleWhat they receive
Issa1ExperimentalAfter local anesthesia, through transverse approach on the middle of dorsal wrist crease the incision is made for 1.5 cm length, then the subcutaneous fat is dissected, soon we see the the palmaris longus tendon or its connection with the carpal ligament , take the ulnar side of the palmaris longus tendon and cut the carpal ligament axillary by scalpel, not going deep with the scalpel to avoid medial nerve injury, soon we see the nerve, we use the scissors to cut the proximal part then the distal part of the carpal ligament by enclosing it between the blades of the scissors, now the full released carpal tunnel most be observed, and one stitch is enough, in this operation most be an assistant exist.
Receives: Procedure: Carpal tunnel release through Mini Transverse Approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients with post surgical trauma

    Measured: Up to eight weeks

Secondary outcomes (2)
  1. Duration of rehabilitation period

    Measured: Up to three weeks

  2. Proportion of patients with cosmetic scar

    Measured: Up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2016 (estimated)
  2. Study startFeb 2013
  3. Primary completionMar 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02766114
Sponsor's protocol ID
Sayed Issa's Approach
Acronym
CTRMTA
Status last verified
May 2016
First submitted
4 May 2016
Last updated
9 May 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Carpal tunnel release through Mini Transverse Approach in people with Carpal Tunnel Syndrome and Carpal Tunnel Release, run by Issa, Abdulhamid Sayed, M.D. at 1 site in Syria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients with post surgical trauma (time frame: Up to eight weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Carpal Tunnel Release Through Mini Transverse Approach | AzTrials